BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26409668)

  • 21. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
    Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
    Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage.
    Chu C; Tokumaru S; Izumi K; Nakagawa K
    Int J Neurosci; 2016; 126(1):62-6. PubMed ID: 25430740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of Prothrombin Complex Concentrate for Warfarin-related Intracranial Hemorrhage].
    Imura J; Yamakawa A; Ikeda M; Morikawa M; Kohmura E
    No Shinkei Geka; 2019 Jun; 47(6):629-636. PubMed ID: 31235665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interhospital Transfer Delays Anticoagulation Reversal in Warfarin-Associated Intracranial Hemorrhage.
    Zepeski A; Rewitzer S; Leira EC; Harland K; Faine BA
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3345-3349. PubMed ID: 30172677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a Pharmacist-Driven Prothrombin Complex Concentrate Protocol on Time to Administration in Patients with Warfarin-associated Intracranial Hemorrhage.
    Corio JL; Sin JH; Hayes BD; Goldstein JN; Fuh L
    West J Emerg Med; 2018 Sep; 19(5):849-854. PubMed ID: 30202498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Effectiveness of Factor VIII Inhibitor Bypassing Activity (FEIBA) and Fresh Frozen Plasma in Oral Anticoagulant-Associated Intracranial Hemorrhage: A Retrospective Analysis.
    Yin EB; Tan B; Nguyen T; Salazar M; Putney K; Gupta P; Suarez JI; Bershad EM
    Neurocrit Care; 2017 Aug; 27(1):51-59. PubMed ID: 28243997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department.
    Maguire M; Fuh L; Goldstein JN; Marshall AL; Levine M; Howell ML; Parry BA; Rosovsky R; Hayes BD
    West J Emerg Med; 2019 Jul; 20(4):619-625. PubMed ID: 31316701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
    Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
    de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
    Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
    Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
    Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.
    Yanamadala V; Walcott BP; Fecci PE; Rozman P; Kumar JI; Nahed BV; Swearingen B
    J Clin Neurosci; 2014 Nov; 21(11):1881-4. PubMed ID: 24953825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
    Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
    Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: Analysis of the prospective multicenter Consortium of Leaders in Traumatic Thromboembolism study.
    Wu YT; Chien CY; Matsushima K; Schellenberg M; Inaba K; Moore EE; Sauaia A; Knudson MM; Martin MJ;
    J Trauma Acute Care Surg; 2023 Nov; 95(5):649-656. PubMed ID: 37314427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
    Edavettal M; Rogers A; Rogers F; Horst M; Leng W
    Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleeding.
    Arachchillage DRJ; Alavian S; Griffin J; Gurung K; Szydlo R; Karawitage N; Laffan M
    Br J Haematol; 2019 Mar; 184(5):808-816. PubMed ID: 30515764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage.
    Switzer JA; Rocker J; Mohorn P; Waller JL; Hughes D; Bruno A; Nichols FT; Hess DC; Natarajan K; Fagan SC
    Stroke; 2012 Sep; 43(9):2500-2. PubMed ID: 22811449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.
    Xie L; Liu X; Phatak H; Mardekian J; Tan W; Baser O; Ramacciotti E
    Am J Ther; 2016; 23(6):e1744-e1753. PubMed ID: 26214203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
    Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries.
    Cooksey GE; Hamilton LA; McMillen JC; Griffard JH; Rowe AS
    Neurocrit Care; 2022 Oct; 37(2):471-478. PubMed ID: 35624388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.